Syqe Medical

Programmable Drug-delivery Inhalation Platform

Health Tech & Life Sciences
Active
Mature Tel Aviv-Yafo Founded 2011
Total raised
$72.7M
Last: Series B 2018-12
Stage
Mature
Founded
2011
Headcount
122
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

Syqe is an innovative MedTech company that developed a breakthrough technology for the administration of medical cannabis by inhalation. The SyqeAir Inhaler is a unique platform that enables physicians and patients to manage cannabis treatment safely and effectively, in compliance with the principles of the standard of care of metered dosing, lowest effective dose, and safety of use. A personalized dose for fast reduction in pain intensity and improvement in sleep quality with minimum adverse effects to establish a daily routine and improve the quality of life alongside the illness.

With each inhalation, a consistent and metered amount of THC is released from a raw medical cannabis inflorescence with a full, uniform, and consistent spectrum of the active ingredients. The cannabis is sealed in a designated cartridge, which is loaded securely into the Inhaler, ready for use. The cartridge contains 60 VaporChips (each the size of a sim card), and each VaporChip contains a uniform amount of raw cannabis inflorescence grown in compliance with GMP’s strict production requirements.

Funding history · 3 rounds · $72.7M total

2018-12
Series B $50.0M
2015-12
Series A $20.0M
2014-12
Seed $2.6M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesRaw MaterialsSemiconductors & Electronics
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2BB2C

Highlights

1 Patents

Tags

cannabispharmaceuticalsdrug-deliverymedical-devicesinhalationpatientsmedical-technologieschronic-painchronic-patientsmedical-cannabisdata-analyticspain-reliefsleep-disorderscns-disorderstherapeutics